JAMA (The Journal of the American Medical Association)

JAMA, or The Journal of the American Medical Association, is a respected medical journal that releases issues 48 times a year, managed by the American Medical Association. It features original research, comprehensive reviews, and insightful editorials that explore various fields within biomedicine. Founded in 1883 by Nathan Smith Davis, the journal has a long-standing history in medical publishing. As of July 1, 2022, Kirsten Bibbins-Domingo from the University of California, San Francisco, took over as editor-in-chief, following Howard Bauchner from Boston University.

International

English

Journal

Outlet metrics

Domain Authority

Ranking

Global

#15103

United States

#5352

Health/Medicine

#56

Traffic sources

Monthly visitors

Articles

Has This Child Experienced Physical Abuse? A Systematic Review

3 days ago | jamanetwork.com | Sonal Shah

The Rational Clinical Examination Has This Child Experienced Physical Abuse?The Rational Clinical Examination Systematic Review US Preventive Services Task Force USPSTF Recommendation: Primary Care Interventions to Prevent Child Maltreatment US Preventive Services Task Force; Michael J. Barry, MD; Wanda K. Nicholson, MD, MPH, MBA; Michael Silverstein, MD, MPH; David Chelmow, MD; Tumaini Rucker Coker, MD, MBA; Esa M.
Anti-Vascular Endothelial Growth Factor Options and Questions for Diabetic Eye Disease Treatment

1 week ago | jamanetwork.com | Adam Glassman

Anti–Vascular Endothelial Growth Factor Options and Questions for Diabetic Eye Disease Treatment Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab Arshad M. Khanani, MD; Peter A. Campochiaro, MD; Jordan M. Graff, MD; Dennis M. Marcus, MD; Daniel Miller, MD; Robert A. Mittra, MD; Carl Regillo, MD; Veeral S.
Evidence-Informed Quality Indicators for Pediatric Trauma Care

1 week ago | jamanetwork.com | Lynne Moore |Université Laval |Natalie Yanchar |Matthew Weiss

Importance Despite the unique physiological characteristics and health care needs of pediatric trauma patients, there is a lack of quality indicators (QIs) based on pediatric-specific evidence to support quality improvement in this population. Objective To develop a consensus-based set of QIs for acute pediatric trauma care that considers evidence on effectiveness, safety, cost-effectiveness, equity, and caregiver perspectives and is applicable in pediatric and nonpediatric trauma centers.
Is Staphylococcus Aureus Still a Problem in the Neonatal Intensive Care Unit?

1 week ago | jamanetwork.com | Lakshmi Srinivasan |David Kaufman

[Skip to Navigation] PDF Full Text Share X Facebook Email LinkedIn Cite Permissions April 14, 2025 JAMA Pediatr. Published online April 14, 2025.
Development, Validation, and Valuation of a Head and Neck Cancer−Specific Health Utility Instrument (HNC-8D): A Head and Neck Cancer International Group Collaborative Study | Head and Neck Cancer | JAMA Otolaryngology-Head & Neck Surgery | JAMA Network

1 week ago | jamanetwork.com | Temerty Faculty |Matthias Büttner |David J. Goldstein |Aaron R. Hansen

Importance Generic health utility instruments lack the discriminative ability to differentiate among health states in patients after head and neck cancer treatment. Objective To develop, validate, and valuate a head and neck cancer−specific health utility measure. Design, Setting, and Participants This psychometric study comprised 2 phases to develop and validate a health utility instrument. The first phase, development and validation, occurred from January 2021 to August 2022.
Olfactory Impairment and Mortality

1 week ago | jamanetwork.com | Nicholas Rowan |Johns Hopkins

PDF Full Text Share X Facebook Email LinkedIn Cite Permissions April 10, 2025 JAMA Otolaryngol Head Neck Surg. Published online April 10, 2025.
New International Editorial Board Member-February 2025

1 week ago | jamanetwork.com | Melina Kibbe

JAMA Surgery would like to thank Avery B. Nathens, MD, MPH, PhD, for his extraordinary service and contributions to the journal as a member of the International Editorial Board for the past 10 years. Effective February 1, 2025, JAMA Surgery is excited to announce the appointment of María F. Jiménez, MD, to the International Editorial Board. María F.
Cost of Neoadjuvant Immunotherapy vs Up-Front Surgery in Cutaneous Squamous Cell Carcinoma: A Post Hoc Analysis of a Nonrandomized Clinical Trial

1 week ago | jamanetwork.com | Shannon Wu |Luis Ramirez |Luis Ramírez |Michelle Chen

Importance There is increasing interest in use of neoadjuvant immunotherapy (NAT) in advanced cutaneous squamous cell carcinoma (cSCC) to reduce surgical morbidity and forego adjuvant therapy, while potentially improving survival outcomes. Objective To assess the cost to Medicare of NAT compared with up-front surgery. Design, Setting, and Participants This cohort study was a post hoc analysis of a phase 2 clinical trial evaluating the feasibility of neoadjuvant atezolizumab.
Risk Factors Associated With Late-Onset Epilepsy in Dementia and Mild Cognitive Impairment

1 week ago | jamanetwork.com | Ifrah Zawar |Mark Quigg |Emily Johnson |Johns Hopkins

Importance The risk of developing epilepsy substantially increases after the age of 60 years (late-onset epilepsy [LOE]), particularly in people with cognitive decline ([PWCD] ie, dementia and/or mild cognitive impairment). Epilepsy is associated with worse cognitive and mortality outcomes in PWCD. Identifying PWCD at risk for developing LOE can facilitate early screening and treatment of epilepsy. Objective To investigate factors associated with LOE in PWCD.
Why Good Palliative Care Clinicians Get Fired

1 week ago | jamanetwork.com | Abby R. Rosenberg |Elliot Rabinowitz |Robert Arnold

[Skip to Navigation] PDF Full Text Share X Facebook Email LinkedIn Cite Permissions April 14, 2025 JAMA. Published online April 14, 2025.